- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Low P/E Dividend Stocks
Hong Kong Pharmaceuticals & Biotech Low P/E Dividend Stocks
Results
6
6 companies
Essex Bio-Technology
Market Cap: HK$1.4b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.55
7D
-11.1%
1Y
-52.0%
Tong Ren Tang Technologies
Market Cap: HK$4.4b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.44
7D
-1.7%
1Y
-36.1%
China Shineway Pharmaceutical Group
Market Cap: HK$6.2b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.24
7D
-0.4%
1Y
-1.9%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.5b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.00
7D
0%
1Y
-26.5%
Pak Fah Yeow International
Market Cap: HK$726.1m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.33
7D
0.4%
1Y
-5.7%
Jacobson Pharma
Market Cap: HK$2.2b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.09
7D
3.8%
1Y
-35.1%